Peptide administration for lung fibrosis treatment using formulation based on medusa technology. develop a sustained release formulation os p144 or p17, loquid or freeze-dried form, for subcutaneous administration route and carry on preclinical and clinical trials.
Invitrotek ltd. Sti. (Istanbul, turkey) and pronto diagnostics ltd. (Tel aviv, israel) will collaborate in developing an assay, based on the targeted next generation sequencing to detect mutations in all thalassemia cases.
To investigate the possibility of developing biomarkers for hcc prognosis and companion diagnostics by using advanced sequencing technologies (ngs) and the data analysis algorithms for a set of target biomarkers.
Development of a comprehensive in silico platform for the prediction and analysis of protein - noble gas interactions and potential therapeutic applications across the entire human proteome.
Determine the optimal use of the superconductive quantum interference device (squid)/mri in low-field nmr. The technical advantages are a simpler magnet, a convenient, low cost magnet system for use in interventional procedures.
The aim is to place healthy hepatic cells into biodegradable biopolymers (such as poly-lactide-co-glycolide), implant them into laboratory animals and demonstrate that the cells survive and function in these animals.
The construction of hybridomas producing monoclonal antibodies for new, more specific diagnostic kits for the detection of colon cancer and some air allergens.
A eureka consortium of scientists from research institutions and 8 leading plant breeding/biotechnology companies will apply innovative molecular techniques to solve urgent quality problems in the most important european cereals.
Development of anti-cancer vaccines. The technology combines a promising tumour antigen with a powerful vaccine vector to provide a specific immunotherapy.
The project addresses the need for improved toxicity assays for better risk assessment to reduce the number of animals used to test toxins and toxic effects. These assays will be developed as kits for commercial availability.